Zenas BioPharma Ownership | Who Owns Zenas BioPharma?


OverviewForecastRevenueFinancialsChart

Zenas BioPharma Ownership Summary


Zenas BioPharma is owned by 3.77% institutional investors, 26.22% insiders, and 70.01% retail investors. Sr one capital management, lp is the largest institutional shareholder, holding 11.95% of ZBIO shares.

ZBIO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockZenas BioPharma3.77%26.22%70.01%
SectorHealthcare Stocks 232.20%10.74%-142.94%
IndustryBiotech Stocks 382.11%10.55%-292.66%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Sr one capital management, lp5.04M11.95%$182.92M
Fmr4.82M11.51%$107.01M
Enavate sciences gp3.76M8.98%$83.50M
Nea management company2.73M6.53%$60.69M
Federated hermes2.72M6.44%$98.60M
Novo2.00M4.78%$44.40M
Fairmount funds management1.89M4.52%$42.02M
Nvp associates1.84M4.39%$40.81M
Blackrock funding, inc. /de1.77M4.19%$64.18M
Deerfield management company, l.p. (series c)1.56M3.73%$34.70M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sr one capital management, lp5.04M25.90%$182.92M
Enavate sciences gp3.76M25.50%$83.50M
Nvp associates1.84M24.58%$40.81M
Pivotal bioventure partners investment advisor779.04K10.00%$17.29M
Fairmount funds management1.89M3.78%$42.02M
Nea management company2.73M3.33%$60.69M
Novo2.00M2.86%$44.40M
Superstring capital management lp96.67K2.11%$2.15M
Vivo capital1.18M2.11%$26.27M
Rock springs capital management lp580.68K0.75%$12.89M

Top Buyers

HolderShares% AssetsChange
Fmr4.82M0.01%1.50M
Federated hermes2.72M0.16%853.74K
Blackrock funding, inc. /de1.77M0.00%538.88K
Vanguard group1.45M0.00%290.31K
Skandinaviska enskilda banken ab (publ)163.86K0.02%163.86K

Top Sellers

HolderShares% AssetsChange
Perceptive advisors---744.03K
Arrowmark colorado824.67K0.34%-269.67K
Novo2.00M2.86%-250.00K
Catalio capital management, lp---215.31K
Eversept partners, lp158.74K0.24%-166.74K

New Positions

HolderShares% AssetsChangeValue
Skandinaviska enskilda banken ab (publ)163.86K0.02%163.86K$5.95M
Invesco145.80K0.00%145.80K$3.24M
Goldman sachs group130.70K0.00%130.70K$4.75M
Stempoint capital lp38.74K0.17%38.74K$860.07K
Swiss national bank31.60K0.00%31.60K$1.15M

Sold Out

HolderChange
Sbi securities-1.00
Mrp capital investments-35.00
Quarry lp-1.13K
Corebridge financial-7.53K
Stoneridge investment partners-10.96K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202522-72.50%1,590,706-95.43%30.05%16-56.76%2-90.91%
Sep 30, 202524-66.67%3,311,937-90.27%70.12%10-78.72%4-63.64%
Jun 30, 20257212.50%34,055,19122.15%811.83%4767.86%11-45.00%
Mar 31, 2025664.76%32,487,0833.18%7713.66%27-42.55%20233.33%
Dec 31, 20246448.84%31,696,95628.35%240.69%4811.63%6-

Recent Insider Transactions


DateNameRoleActivityValue
Feb 11, 2026Lu Hongbo-Buy$584.66K
Feb 12, 2026Allen Patricia L-Buy$132.50K
Feb 13, 2026Allen Patricia L-Buy$109.66K
Feb 12, 2026Allen Patricia L-Buy$138.74K
Feb 12, 2026Allen Patricia L-Buy$118.85K

Insider Transactions Trends


DateBuySell
2026 Q19-
2025 Q48-
2025 Q2--
2025 Q12-
2024 Q44-

ZBIO Ownership FAQ


Who Owns Zenas BioPharma?

Zenas BioPharma shareholders are primarily institutional investors at 3.77%, followed by 26.22% insiders and 70.01% retail investors. The average institutional ownership in Zenas BioPharma's industry, Biotech Stocks , is 382.11%, which Zenas BioPharma falls below.

Who owns the most shares of Zenas BioPharma?

Zenas BioPharma’s largest shareholders are Sr one capital management, lp (5.04M shares, 11.95%), Fmr (4.82M shares, 11.51%), and Enavate sciences gp (3.76M shares, 8.98%). Together, they hold 32.45% of Zenas BioPharma’s total shares outstanding.

Does Blackrock own Zenas BioPharma?

BlackRock is not among the top 10 institutional shareholders of Zenas BioPharma.

Who is Zenas BioPharma’s biggest shareholder by percentage of total assets invested?

Sr one capital management, lp is Zenas BioPharma’s biggest shareholder by percentage of total assets invested, with 25.90% of its assets in 5.04M Zenas BioPharma shares, valued at 182.92M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools